Holen Sie sich die Stockscreener-App
3.555
0.99%
0.035
Handel nachbörslich:
3.64
0.085
+2.39%
Schlusskurs vom Vortag:
$3.52
Offen:
$3.56
24-Stunden-Volumen:
45,126
Relative Volume:
0.04
Marktkapitalisierung:
$5.84M
Einnahmen:
$12.31M
Nettoeinkommen (Verlust:
$-5.08M
KGV:
-3.7819
EPS:
-0.94
Netto-Cashflow:
$-5.20M
1W Leistung:
-3.40%
1M Leistung:
+16.94%
6M Leistung:
+36.73%
1J Leistung:
-57.98%
1-Tages-Spanne:
$3.41
$3.5985
1-Wochen-Bereich:
$3.41
$3.75
52-Wochen-Spanne:
$1.75
$8.624
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Firmenname
Sonoma Pharmaceuticals Inc
Sektor
Telefon
800-759-9305
Adresse
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Vergleichen Sie SNOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.555 | 6.05M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten
What analysts say about Sonoma Pharmaceuticals Inc. stockHigh-return market picks - jammulinksnews.com
Sonoma Pharmaceuticals Inc. Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
What drives Sonoma Pharmaceuticals Inc. stock priceUnstoppable trading performance - jammulinksnews.com
Dakota Gold Corp. Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com
Is Sonoma Pharmaceuticals Inc. a good long term investmentExceptional risk-adjusted gains - Autocar Professional
What drives Teladoc Health Inc. stock priceRapidly growing investment returns - jammulinksnews.com
National Highways Infra Trust (NHIT) Expands into New MarketFree Stock Index Interpretation - Jammu Links News
Best Startups to Watch in India Expert Trader GroupUnmatched market performance - jammulinksnews.com
GNL.PRB Stock Analysis and ForecastUnrivaled growth potential - jammulinksnews.com
Why Unicycive Therapeutics Inc. stock is on top investor watchlistsRisk Aware High Growth Picks - Newser
How to Monetize Cloud Based Data Warehousing SolutionsReal Time Stock Signal - Newser
Why Alector Inc. stock attracts strong analyst attentionLong Term Safe Yield Focus - Newser
Why Sonoma Pharmaceuticals Inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
What makes SaverOne 2014 Ltd. Depositary Receipt stock price move sharplyCapital Doubling Tips - Newser
How Sonoma Pharmaceuticals Inc. stock performs during market volatilityReliable High Profit Alerts - Newser
How NOEMW stock performs during market volatilityFree Risk Assessment Services - Newser
What makes Sonoma Pharmaceuticals Inc. stock price move sharplyFree Deep Market Trend Analysis - Newser
How NI Holdings Inc. stock performs during market volatilityMomentum Swing Watchlist - Newser
How Fortrea Holdings Inc. stock performs during market volatilityProfitable Yet Secure Picks - Newser
What makes COGT stock price move sharplyFree Stock Market Courses - Newser
What makes Origin Materials Inc. Equity Warrant stock price move sharplyPredictable Return Stock Picks - Newser
How FERA stock performs during market volatility10x Potential Stocks - Newser
How Bar Harbor Bankshares stock performs during market volatilityHigh Accuracy Alerts - Newser
VOXEL(voxies) News and UpdatesCarefully Curated High Return Stocks - Newser
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance
U.S. Animal Wound Care Market Size | Industry Report, 2030 - Grand View Research
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Pass Above 200 Day Moving Average – Time to Sell? - Defense World
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Is Sonoma Pharmaceuticals, Inc. technically bullish or bearish? - MarketsMojo
Global Dental Market Set to Reach USD 19.13 Bn by 2032, Driven by 7.5% CAGR | Coherent Market Insights - newstrail.com
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | SNOA Stock News - GuruFocus
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results - ACCESS Newswire
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):